Dear Borders NHS Board,

Please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.

A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:

i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer

I sincerely thank you for taking the time to answer these questions.

Yours faithfully,

David Elder